EZL: 6-ethoxy-1,3-benzothiazole-2-sulfonamide
EZL is a Ligand Of Interest in 5TT3 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 5TT3_EZL_E_303 | 82% | 5% | 0.119 | 0.974 | 2.08 | 3.44 | 2 | 9 | 2 | 0 | 100% | 1 |
| 5TT3_EZL_H_303 | 79% | 5% | 0.121 | 0.969 | 2.07 | 3.44 | 2 | 9 | 1 | 0 | 100% | 1 |
| 5TT3_EZL_G_303 | 79% | 5% | 0.13 | 0.976 | 2.08 | 3.44 | 2 | 9 | 0 | 0 | 100% | 1 |
| 5TT3_EZL_A_303 | 76% | 5% | 0.131 | 0.969 | 2.07 | 3.44 | 2 | 9 | 3 | 0 | 100% | 1 |
| 5TT3_EZL_F_302 | 69% | 5% | 0.141 | 0.958 | 2.08 | 3.44 | 2 | 9 | 1 | 0 | 100% | 1 |
| 5TT3_EZL_C_303 | 69% | 5% | 0.15 | 0.966 | 2.06 | 3.44 | 2 | 9 | 0 | 0 | 100% | 1 |
| 5TT3_EZL_B_303 | 66% | 5% | 0.138 | 0.943 | 2.07 | 3.45 | 2 | 9 | 1 | 0 | 100% | 1 |
| 6QL2_EZL_A_306 | 100% | 14% | 0.048 | 0.996 | 1.33 | 2.65 | 1 | 8 | 0 | 0 | 100% | 1 |
| 3DD0_EZL_A_301 | 96% | 5% | 0.075 | 0.987 | 1.75 | 3.8 | 2 | 11 | 0 | 0 | 100% | 1 |
| 3DCW_EZL_A_301 | 94% | 11% | 0.082 | 0.981 | 1.72 | 2.64 | 3 | 9 | 0 | 0 | 100% | 1 |
| 3CAJ_EZL_A_265 | 93% | 29% | 0.077 | 0.972 | 1.32 | 1.63 | 2 | 5 | 0 | 0 | 100% | 1 |
| 6BCC_EZL_A_302 | 93% | 19% | 0.085 | 0.987 | 1.7 | 1.93 | 2 | 5 | 0 | 0 | 96% | 1 |
